Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

NCT01653041 is registered in ClinicalTrials.gov with Hospital do Rim e Hipertensão as lead sponsor.

NCT NCT01653041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01653041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors
Lead sponsor
Hospital do Rim e Hipertensão
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
April 30, 2015
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation